Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Operating Expenses | 14,794 | 9,319 | 0 |
| Operating Income | -14,794 | -9,319 | N/A |
| Other Income | -64 | -1,753 | 0 |
| Pre-tax Income | -14,858 | -11,072 | 0 |
| Net Income Continuous | -14,858 | -11,072 | N/A |
| Net Income | $-14,858 | $-11,072 | $N/A |
| EPS Basic Total Ops | -59.32 | -49.38 | N/A |
| EPS Basic Continuous Ops | -58.96 | -48.78 | N/A |
| EPS Diluted Total Ops | -59.32 | -49.38 | N/A |
| EPS Diluted Continuous Ops | -58.96 | -48.78 | N/A |
| EBITDA(a) | $-14,555 | $-9,061 | $N/A |